[Real-world evidence : Benefits and limitations in multiple sclerosis research].

CONCLUSION: There is still a need for high-quality, comprehensive, and valid RWE data as these data cover additional aspects of patient care and expand the data available by complementary information. Further development of an integrative RWE approach requires cooperation at various levels with the aim of the best possible standardization and harmonization of clinical MS data. PMID: 28776214 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28776214?dopt=Abstract

Source: Der Nervenarzt - August 3, 2017 Category: Neurology Authors: Ziemssen T, Rothenbacher D, Kuhle J, Berger T Tags: Nervenarzt Source Type: research

More News: Clinical Trials | Databases & Libraries | Electronic Medical Records (EMR) | Multiple Sclerosis | Study